D. Western Therapeutics Institute, Inc. (FRA:6DW)

FRA:6DW Revenue

D. Western Therapeutics Institute had revenue of 123.86M JPY in the quarter ending September 30, 2025, a decrease of -1.22%. This brings the company's revenue in the last twelve months to 419.76M, down -9.39% year-over-year. In the year 2024, D. Western Therapeutics Institute had annual revenue of 471.00M with 10.05% growth.

• Revenue (ttm): 419.76M JPY
• Revenue Growth: -9.39%
• P/S Ratio: 12.48
• Revenue / Employee: 19.99M JPY
• Employees: 21
• Market Cap: 30.18M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	471.00M	43.00M	10.05%
Dec 31, 2023	428.00M	-20.00M	-4.46%
Dec 31, 2022	448.00M	34.00M	8.21%
Dec 31, 2021	414.00M	59.00M	16.62%
Dec 31, 2020	355.00M	-225.00M	-38.79%